Literature DB >> 28416635

VprBP/DCAF1 Regulates the Degradation and Nonproteolytic Activation of the Cell Cycle Transcription Factor FoxM1.

Xianxi Wang1, Anthony Arceci1,2, Kelly Bird3, Christine A Mills1,4, Rajarshi Choudhury1, Jennifer L Kernan1,4, Chunxiao Zhou1,5, Victoria Bae-Jump1,5, Albert Bowers1,3, Michael J Emanuele6,2,4.   

Abstract

The oncogenic transcription factor FoxM1 plays a vital role in cell cycle progression, is activated in numerous human malignancies, and is linked to chromosome instability. We characterize here a cullin 4-based E3 ubiquitin ligase and its substrate receptor, VprBP/DCAF1 (CRL4VprBP), which we show regulate FoxM1 ubiquitylation and degradation. Paradoxically, we also found that the substrate receptor VprBP is a potent FoxM1 activator. VprBP depletion reduces expression of FoxM1 target genes and impairs mitotic entry, whereas ectopic VprBP expression strongly activates a FoxM1 transcriptional reporter. VprBP binding to CRL4 is reduced during mitosis, and our data suggest that VprBP activation of FoxM1 is ligase independent. This implies a nonproteolytic activation mechanism that is reminiscent of, yet distinct from, the ubiquitin-dependent transactivation of the oncoprotein Myc by other E3s. Significantly, VprBP protein levels were upregulated in high-grade serous ovarian patient tumors, where the FoxM1 signature is amplified. These data suggest that FoxM1 abundance and activity are controlled by VprBP and highlight the functional repurposing of E3 ligase substrate receptors independent of the ubiquitin system.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  FoxM1; cell cycle; cullin ring ligase; transcriptional regulation; ubiquitination

Mesh:

Substances:

Year:  2017        PMID: 28416635      PMCID: PMC5472828          DOI: 10.1128/MCB.00609-16

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress.

Authors:  Flore Kruiswijk; Laurensia Yuniati; Roberto Magliozzi; Teck Yew Low; Ratna Lim; Renske Bolder; Shabaz Mohammed; Christopher G Proud; Albert J R Heck; Michele Pagano; Daniele Guardavaccaro
Journal:  Sci Signal       Date:  2012-06-05       Impact factor: 8.192

2.  FoxM1 is required for execution of the mitotic programme and chromosome stability.

Authors:  Jamila Laoukili; Matthijs R H Kooistra; Alexandra Brás; Jos Kauw; Ron M Kerkhoven; Ashby Morrison; Hans Clevers; René H Medema
Journal:  Nat Cell Biol       Date:  2005-01-16       Impact factor: 28.824

3.  FoxM1 is degraded at mitotic exit in a Cdh1-dependent manner.

Authors:  Jamila Laoukili; Monica Alvarez-Fernandez; Marie Stahl; René H Medema
Journal:  Cell Cycle       Date:  2008-09-10       Impact factor: 4.534

4.  The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism.

Authors:  Xi Chen; Gerd A Müller; Marianne Quaas; Martin Fischer; Namshik Han; Benjamin Stutchbury; Andrew D Sharrocks; Kurt Engeland
Journal:  Mol Cell Biol       Date:  2012-10-29       Impact factor: 4.272

5.  In vivo degradation of a transcriptional regulator: the yeast alpha 2 repressor.

Authors:  M Hochstrasser; A Varshavsky
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

6.  SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock.

Authors:  Ray-Chang Wu; Qin Feng; David M Lonard; Bert W O'Malley
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

7.  Identification of new mechanisms of cellular response to chemotherapy by tracking changes in post-translational modifications by ubiquitin and ubiquitin-like proteins.

Authors:  Thomas Bonacci; Stéphane Audebert; Luc Camoin; Emilie Baudelet; Ghislain Bidaut; Maxime Garcia; Ini-Isabée Witzel; Neil D Perkins; Jean-Paul Borg; Juan-Lucio Iovanna; Philippe Soubeyran
Journal:  J Proteome Res       Date:  2014-04-02       Impact factor: 4.466

8.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

9.  Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover.

Authors:  Meng-Kwang Marcus Tan; Hui-Jun Lim; Eric J Bennett; Yang Shi; J Wade Harper
Journal:  Mol Cell       Date:  2013-09-12       Impact factor: 17.970

10.  CRL4-DDB1-VPRBP ubiquitin ligase mediates the stress triggered proteolysis of Mcm10.

Authors:  Manpreet Kaur; Md Muntaz Khan; Ananya Kar; Aparna Sharma; Sandeep Saxena
Journal:  Nucleic Acids Res       Date:  2012-05-08       Impact factor: 16.971

View more
  16 in total

1.  Hematopoietic PBX-interacting protein is a substrate and an inhibitor of the APC/C-Cdc20 complex and regulates mitosis by stabilizing cyclin B1.

Authors:  Saratchandra Singh Khumukcham; Venkata Subramanyam Kumar Samanthapudi; Vasudevarao Penugurti; Anita Kumari; P S Kesavan; Loka Reddy Velatooru; Siva Reddy Kotla; Aprotim Mazumder; Bramanandam Manavathi
Journal:  J Biol Chem       Date:  2019-05-17       Impact factor: 5.157

2.  The E3 Ubiquitin Ligase SCF(Cyclin F) Transmits AKT Signaling to the Cell-Cycle Machinery.

Authors:  Rajarshi Choudhury; Thomas Bonacci; Xianxi Wang; Andrew Truong; Anthony Arceci; Yanqiong Zhang; Christine A Mills; Jennifer L Kernan; Pengda Liu; Michael J Emanuele
Journal:  Cell Rep       Date:  2017-09-26       Impact factor: 9.423

3.  DCAF12 promotes apoptosis and inhibits NF-κB activation by acting as an endogenous antagonist of IAPs.

Authors:  Dongyue Jiao; Yingji Chen; Yalan Wang; Huiru Sun; Qing Shi; Liang Zhang; Xiaying Zhao; Yajuan Liu; Huiying He; Zeheng Lv; Chuan Liu; Pingzhao Zhang; Kun Gao; Yan Huang; Yao Li; Liang Li; Chenji Wang
Journal:  Oncogene       Date:  2022-04-22       Impact factor: 9.867

Review 4.  Structure and function of MuvB complexes.

Authors:  Gerd A Müller; Anushweta Asthana; Seth M Rubin
Journal:  Oncogene       Date:  2022-04-26       Impact factor: 8.756

Review 5.  Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy.

Authors:  Sang-Min Jang; Christophe E Redon; Mirit I Aladjem
Journal:  Front Mol Biosci       Date:  2018-03-13

6.  An order-to-disorder structural switch activates the FoxM1 transcription factor.

Authors:  Aimee H Marceau; Caileen M Brison; Santrupti Nerli; Heather E Arsenault; Andrew C McShan; Eefei Chen; Hsiau-Wei Lee; Jennifer A Benanti; Nikolaos G Sgourakis; Seth M Rubin
Journal:  Elife       Date:  2019-05-28       Impact factor: 8.140

Review 7.  The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Brian J North; Kaixiong Tao; Pengbo Zhou; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-12-30       Impact factor: 10.680

Review 8.  FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer.

Authors:  Cassie Liu; Carter J Barger; Adam R Karpf
Journal:  Cancers (Basel)       Date:  2021-06-19       Impact factor: 6.639

Review 9.  The Dominant Role of Forkhead Box Proteins in Cancer.

Authors:  Duc-Hiep Bach; Nguyen Phuoc Long; Thi-Thu-Trang Luu; Nguyen Hoang Anh; Sung Won Kwon; Sang Kook Lee
Journal:  Int J Mol Sci       Date:  2018-10-22       Impact factor: 5.923

Review 10.  Regulation of the master regulator FOXM1 in cancer.

Authors:  Guo-Bin Liao; Xin-Zhe Li; Shuo Zeng; Cheng Liu; Shi-Ming Yang; Li Yang; Chang-Jiang Hu; Jian-Ying Bai
Journal:  Cell Commun Signal       Date:  2018-09-12       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.